Cargando…
COVID-19 Vaccination: From Interesting Agent to the Patient
The vaccination for the novel Coronavirus (COVID-19) is undergoing its final stages of analysis and testing. It is an impressive feat under the circumstances that we are on the verge of a potential breakthrough vaccination. This will help reduce the stress for millions of people around the globe, he...
Autor principal: | Daou, Anis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913564/ https://www.ncbi.nlm.nih.gov/pubmed/33546347 http://dx.doi.org/10.3390/vaccines9020120 |
Ejemplares similares
-
SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus
por: Elmancy, Laila, et al.
Publicado: (2022) -
Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest
por: Moss, Paul, et al.
Publicado: (2022) -
assessment of Vaccine Interest in Unvaccinated COVID-19–positive inpatients
por: Stancill, Lisa, et al.
Publicado: (2022) -
Global interest in vaccines during the COVID‐19 pandemic: Evidence from Google Trends
por: Khakimova, Aida, et al.
Publicado: (2022) -
Bee Products as Interesting Natural Agents for the Prevention and Treatment of Common Cardiovascular Diseases
por: Olas, Beata
Publicado: (2022)